Hereditary angioedema: Current and emerging treatment options

Anesthesia and Analgesia

Volumn 110, Issue 5, 2010, Pages 1271-1280

  Levy, Jerrold H ^a   Freiberger, Douglas J ^a   Roback, John ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMINOCAPROIC ACID; ANALGESIC AGENT; ANDROGEN; ANTIEMETIC AGENT; ANTIFIBRINOLYTIC AGENT; ANTIHISTAMINIC AGENT; BERINERT P; BLOOD CLOTTING FACTOR 12; COMPLEMENT COMPONENT C1S INHIBITOR; DANAZOL; ECALLANTIDE; ESTROGEN; FRESH FROZEN PLASMA; KALLIKREIN; KALLIKREIN INHIBITOR; PREKALLIKREIN; RHUCIN; STANOZOLOL; STEROID; TIBOLONE; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ACNE; ADENOMA; ALOPECIA; ANGIONEUROTIC EDEMA; ANXIETY; CHROMOSOME 11; CLINICAL FEATURE; CLINICAL TRIAL; CONFUSION; DIARRHEA; DIZZINESS; DRUG DOSE TITRATION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DYSGEUSIA; ENDOTRACHEAL INTUBATION; ENZYME ACTIVITY; FEVER; FLUID RESUSCITATION; GENE MUTATION; HEADACHE; HEMATURIA; HIRSUTISM; HUMAN; HYPERLIPIDEMIA; HYPERSENSITIVITY; HYPERTENSION; HYPOTENSION; INJECTION SITE REACTION; LARYNGEAL MASK; LIBIDO; LIVER TOXICITY; MENSTRUAL IRREGULARITY; MUSCLE WEAKNESS; MYALGIA; NAUSEA; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PRURITUS; REVIEW; RHINOPHARYNGITIS; SIDE EFFECT; SKIN SWELLING; THROMBOSIS; UNITED STATES; UNSPECIFIED SIDE EFFECT; UPPER ABDOMINAL PAIN; UPPER RESPIRATORY TRACT INFECTION; VISUAL IMPAIRMENT; VOMITING; WEIGHT GAIN;

EID: 77951715680     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181d7ac98     Document Type: Review

References (126)

1. Beck P, Willis D, Davies GT, Lachmann PJ, Sussman M. A family study of hereditary angioneurotic oedema. Q J Med 1973;42:317-339
2. Bowen T, Cicardi M, Bork K, Zuraw B, Frank M, Ritchie B, Farkas H, Varga L, Zingale LC, Binkley K, Wagner E, Adomaitis P, Brosz K, Burnham J, Warrington R, Kalicinsky C, Mace S, McCusker C, Schellenberg R, Celeste L, Hebert J, Valentine K, Poon MC, Serushago B, Neurath D, Yang W, Lacuesta G, Issekutz A, Hamed A, Kamra P, Dean J, Kanani A, Stark D, Rivard GE, Leith E, Tsai E, Waserman S, Keith PK, page D, Marchesin S, Longhurst HJ, Kreuz W, Rusicke E, Martinez-Saguer I, Aygoren-Pursun E, Harmat G, Fust G, Li H, Bouillet L, Caballero T, Moldovan D, Spath PJ, Smith-Foltz S, Nagy I, Nielsen EW, Bucher C, Nordenfelt P, Xiang ZY. Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol 2008;100:S30-40
3. Moore GP, Hurley WT, Pace SA. Hereditary angioedema. Ann Emerg Med 1988;17:1082-1086
4. Blok PH, Baarsma EA. Hereditary Angio-Edema (HAE). J Laryngol Otol 1984;98:59-63
5. Kaplan AP, Greaves MW. Angioedema. J Am Acad Dermatol 2005;53:373- 88; quiz 389-392
6. Donaldson VH, Evans RR. A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C'1-esterase. Am J Med 1963;35:37-44
7. Agostoni A, Aygoren-Pursun E, Binkley KE, Blanch A, Bork K, Bouillet L, Bucher C, Castaldo AJ, Cicardi M, Davis AE, De Carolis C, Drouet C, Duponchel C, Farkas H, Fay K, Fekete B, Fischer B, Fontana L, Fust G, Giacomelli R, Groner A, Hack CE, Harmat G, Jakenfelds J, Juers M, Kalmar L, Kaposi PN, Karadi I, Kitzinger A, Kollar T, Kreuz W, Lakatos P, Longhurst HJ, Lopez-Trascasa M, Martinez-Saguer I, Monnier N, Nagy I, Nemeth E, Nielsen EW, Nuijens JH, O'Grady C, Pappalardo E, Penna V, Perricone C, Perricone R, Rauch U, Roche O, Rusicke E, Spath PJ, Szendei G, Takacs E, Tordai A, Truedsson L, Varga L, Visy B, Williams K, Zanichelli A, Zingale L. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 2004;114:S51-131
8. Fields T, Ghebrehiwet B, Kaplan AP. Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin. J Allergy Clin Immunol 1983;72:54-60
9. Han ED, MacFarlane RC, Mulligan AN, Scafidi J, Davis AE III. Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. J Clin Invest 2002;109:1057-1063
10. Juhlin L, Michaelsson G. Vascular reactions in hereditary angioneurotic edema. Acta Derm Venereol 1969;49:20-25
11. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angio-oedema. Lancet 1998;351:1693-1697
12. Schapira M, Silver LD, Scott CF, Schmaier AH, Prograis LJ Jr, Curd JG, Colman RW. Prekallikrein activation and highmolecular- weight kininogen consumption in hereditary angioedema. N Engl J Med 1983;308:1050-1053
13. Shoemaker LR, Schurman SJ, Donaldson VH, Davis AE III. Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities. Clin Exp Immunol 1994;95:22-28
14. Zahedi R, Wisnieski J, Davis AE III. Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases. J Immunol 1997;159:983-988
15. Prada AE, Zahedi K, Davis AE III. Regulation of C1 inhibitor synthesis. Immunobiology 1998;199:377-388
16. Freiberger T, Vyskocilova M, Kolarova L, Kuklinek P, Krystufkova O, Lahodna M, Hanzlikova J, Litzman J. Exon 1 polymorphism of the B2BKR gene does not influence the clinical status of patients with hereditary angioedema. Hum Immunol 2002;63:492-494
17. Tosi M, Duponchel C, Bourgarel P, Colomb M, Meo T. Molecular cloning of human C1 inhibitor: sequence homologies with alpha 1-antitrypsin and other members of the serpins superfamily. Gene 1986;42:265-272
18. Davis AE III. C1 inhibitor and hereditary angioneurotic edema. Annu Rev Immunol 1988;6:595-628
19. Pappalardo E, Zingale LC, Cicardi M. C1 inhibitor gene expression in patients with hereditary angioedema: quantitative evaluation by means of real-time RT-PCR. J Allergy Clin Immunol 2004;114:638-644
20. Quastel M, Harrison R, Cicardi M, Alper CA, Rosen FS. Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema. J Clin Invest 1983;71:1041-1046
21. Cichon S, Martin L, Hennies HC, Muller F, Van Driessche K, Karpushova A, Stevens W, Colombo R, Renne T, Drouet C, Bork K, Nothen MM. Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am J Hum Genet 2006;79:1098-1104
22. Dewald G, Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun 2006;343:1286-1289
23. Farsetti A, Misiti S, Citarella F, Felici A, Andreoli M, Fantoni A, Sacchi A, Pontecorvi A. Molecular basis of estrogen regulation of Hageman factor XII gene expression. Endocrinology 1995;136:5076-5083
24. Bork K, Gul D, Hardt J, Dewald G. Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course. Am J Med 2007;120:987-992
25. Metzger WJ, Grem J, Halverson PC, Sharath MD, Shulan DJ, Lawton W, Weiler JM. C1 INH deficiency and angioedema: a spectrum of disease. Part two. Ann Allergy 1984;52:285-290
26. Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med 2008;359:1027-1036
27. Bork K, Siedlecki K, Bosch S, Schopf RE, Kreuz W. Asphyxiation by laryngeal edema in patients with hereditary angioedema. Mayo Clin Proc 2000;75:349-354
28. Temino VM, Peebles RS Jr. The spectrum and treatment of angioedema. Am J Med 2008;121:282-286
29. Bork K, Koch P. Episodes of severe dyspnea caused by snoring-induced recurrent edema of the soft palate in hereditary angioedema. J Am Acad Dermatol 2001;45:968-969
30. Frank MM, Gelfand JA, Atkinson JP. Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med 1976;84:580-593
31. Karlis V, Glickman RS, Stern R, Kinney L. Hereditary angioedema: case report and review of management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83:462-464
32. Bowen T, Hebert J, Ritchie B, Burnham J, MacSween M, Warrington R, Yang W, Issekutz A, Karitsiotis N, McCombie N, Giulivi T. Management of hereditary angioedema: a Canadian approach. Transfus Apher Sci 2003;29:205-214
33. Bork K, Meng G, Staubach P, Hardt J. Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema. Transfusion 2005;45:1774-1784
34. Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore) 1992;71:206-215
35. Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 2006;119:267-274
36. De Backer AI, De Schepper AM, Vandevenne JE, Schoeters P, Michielsen P, Stevens WJ. CT of angioedema of the small bowel. AJR Am J Roentgenol 2001;176:649-652
37. Dinkel HP, Maroske J, Schrod L. Sonographic appearances of the abdominal manifestations of hereditary angioedema. Pediatr Radiol 2001;31:296-298
38. Hara T, Shiotani A, Matsunaka H, Yamanishi T, Oka H, Ishiguchi T, Saika A, Itoh H, Nishioka S. Hereditary angioedema with gastrointestinal involvement: endoscopic appearance. Endoscopy 1999;31:322-324
39. Farkas H, Harmat G, Fust G, Varga L, Visy B. Clinical management of hereditary angio-oedema in children. Pediatr Allergy Immunol 2002;13:153-161
40. Zuraw BL. Hereditary angiodema: a current state-of-the-art review, IV: short- and long-term treatment of hereditary angioedema: out with the old and in with the new? Ann Allergy Asthma Immunol 2008;100:S13-18
41. Karim Y, Griffiths H, Deacock S. Normal complement C4 values do not exclude hereditary angioedema. J Clin Pathol 2004;57:213-214
42. Markovic SN, Inwards DJ, Phyliky RP. Acquired C1 esterase inhibitor deficiency. Ann Intern Med 2000;133:839
43. Gompels MM, Lock RJ, Morgan JE, Osborne J, Brown A, Virgo PF. A multicentre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency. J Clin Pathol 2002;55:145-147
44. Bouillet L, Ponard D, Rousset H, Cichon S, Drouet C. A case of hereditary angio-oedema type III presenting with C1- inhibitor cleavage and a missense mutation in the F12 gene. Br J Dermatol 2007;156:1063-1065
45. Weiler CR, van Dellen RG. Genetic test indications and interpretations in patients with hereditary angioedema. Mayo Clin Proc 2006;81:958-972
46. Guarino MD, Perricone C, Guarino S, Gambardella S, D'Apice MR, Fontana L, Novelli G, Perricone R. Denaturing HPLC in laboratory diagnosis of hereditary angioedema. J Allergy Clin Immunol 2007;120:962-965
47. Nielsen EW, Johansen HT, Holt J, Mollnes TE. C1 inhibitor and diagnosis of hereditary angioedema in newborns. Pediatr Res 1994;35:184-187
48. Donaldson VH, Rosen FS. Hereditary angioneurotic edema: a clinical survey. Pediatrics 1966;37:1017-1027
49. Gwynn CM. Therapy in hereditary angioneurotic oedema. Arch Dis Child 1974;49:636-640
50. Bork K, Hardt J, Schicketanz KH, Ressel N. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med 2003;163:1229-1235
51. Farkas H, Varga L, Szeplaki G, Visy B, Harmat G, Bowen T. Management of hereditary angioedema in pediatric patients. Pediatrics 2007;120:e713-22
52. Gompels MM, Lock RJ, Abinun M, Bethune CA, Davies G, Grattan C, Fay AC, Longhurst HJ, Morrison L, Price A, Price M, Watters D. C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005;139:379-394
53. Roach B, Kim Y, Jerome E, Michael AF. Influence of age and sex on serum complement components in children. Am J Dis Child 1981;135:918-920
54. Bowen T, Cicardi M, Farkas H, Bork K, Kreuz W, Zingale L, Varga L, Martinez-Saguer I, Aygoren-Pursun E, Binkley K, Zuraw B, Davis A III, Hebert J, Ritchie B, Burnham J, Castaldo A, Menendez A, Nagy I, Harmat G, Bucher C, Lacuesta G, Issekutz A, Warrington R, Yang W, Dean J, Kanani A, Stark D, McCusker C, Wagner E, Rivard GE, Leith E, Tsai E, Mac- Sween M, Lyanga J, Serushago B, Leznoff A, Waserman S, de Serres J. Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. J Allergy Clin Immunol 2004;114:629-637
55. Gelfand JA, Sherins RJ, Alling DW, Frank MM. Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. N Engl J Med 1976;295:1444-1448
56. Pappalardo E, Zingale LC, Cicardi M. Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with Danazol. Immunol Lett 2003;86:271-276
57. Sloane DE, Lee CW, Sheffer AL. Hereditary angioedema: safety of long-term stanozolol therapy. J Allergy Clin Immunol 2007;120:654-658
58. Zurlo JJ, Frank MM. The long-term safety of danazol in women with hereditary angioedema. Fertil Steril 1990;54:64-72
59. Bork K, Pitton M, Harten P, Koch P. Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema. Lancet 1999;353:1066-1067
60. Cicardi M, Castelli R, Zingale LC, Agostoni A. Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. J Allergy Clin Immunol 1997;99:194-196
61. Sheffer AL, Fearon DT, Austen KF. Hereditary angioedema: a decade of management with stanozolol. J Allergy Clin Immunol 1987;80:855-860
62. Szeplaki G, Varga L, Valentin S, Kleiber M, Karadi I, Romics L, Fust G, Farkas H. Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema. J Allergy Clin Immunol 2005;115:864-869
63. Cicardi M, Zingale L. How do we treat patients with hereditary angioedema. Transfus Apher Sci 2003;29:221-227
64. Ott HW, Mattle V, Hadziomerovic D, Licht P, Doinghaus K, Rubbert A, Manger K, Manger B, Kalden J, Wildt L. Treatment of hereditary angioneurotic oedema (HANE) with tibolone. Clin Endocrinol (Oxf) 2007;66:180-184
65. Wallace EM, Perkins SJ, Sim RB, Willis AC, Feighery C, Jackson J. Degradation of C1-inhibitor by plasmin: implications for the control of inflammatory processes. Mol Med 1997;3:385-396
66. Levi M, Roem D, Kamp AM, de Boer JP, Hack CE, ten Cate JW. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo. Thromb Haemost 1993;69:141-146
67. Cugno M, Cicardi M, Agostoni A. Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid. J Allergy Clin Immunol 1994;93:870-876
68. Blohme G. Treatment of hereditary angioneurotic oedema with tranexamic acid. A random double-blind cross-over study. Acta Med Scand 1972;192:293-298
69. Frank MM, Sergent JS, Kane MA, Alling DW. Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study. N Engl J Med 1972;286: 808-812
70. Sheffer AL, Austen KF, Rosen FS. Tranexamic acid therapy in hereditary angioneurotic edema. N Engl J Med 1972;287:452-454
71. Van Dellen RG. Long-term treatment of C1 inhibitor deficiency with epsilon-aminocaproic acid in two patients. Mayo Clin Proc 1996;71:1175-1178
72. Berntorp E, Follrud C, Lethagen S. No increased risk of venous thrombosis in women taking tranexamic acid. Thromb Haemost 2001;86:714-715
73. Dalmau A, Sabate A, Koo M, Rafecas A, Figueras J, Jaurrieta E. Prophylactic use of tranexamic acid and incidence of arterial thrombosis in liver transplantation. Anesth Analg 2001;93:516
74. Cohen G, Peterson A. Treatment of hereditary angioedema with frozen plasma. Ann Allergy 1972;30:690-692
75. Pickering RJ, Good RA, Kelly JR, Gewurz H. Replacement therapy in hereditary angioedema. Successful treatment of two patients with fresh frozen plasma. Lancet 1969;1: 326-330
76. Farkas H, Jakab L, Temesszentandrasi G, Visy B, Harmat G, Fust G, Szeplaki G, Fekete B, Karadi I, Varga L. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy. J Allergy Clin Immunol 2007;120:941-947
77. Chapman CE, Stainsby D, Jones H, Love E, Massey E, Win N, Navarrete C, Lucas G, Soni N, Morgan C, Choo L, Cohen H, Williamson LM. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009;49:440-452
78. Bork K, Staubach P, Hardt J. Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angiooedema. Allergy 2008;63:751-757
79. Zuraw BL, Christiansen SC. New promise and hope for treating hereditary angioedema. Expert Opin Investig Drugs 2008;17:697-706
80. De Serres J, Groner A, Lindner J. Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert P) in hereditary angioedema: a review. jean.de.serres@aventis.com. Transfus Apher Sci 2003;29:247-254
81. Weimer T, Streichert S, Watson C, Groner A. High-titer screening PCR: a successful strategy for reducing the parvovirus B19 load in plasma pools for fractionation. Transfusion 2001;41:1500-1504
82. Klarmann D, Kreuz W, Joseph-Steiner J, Ehrenforth S. Hepatitis C and pasteurized C1-inhibitor concentrate. Transfusion 1996;36:84-85
83. Waytes AT, Rosen FS, Frank MM. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. N Engl J Med 1996;334:1630-1634
84. Longhurst HJ, Bork K. Hereditary angioedema: causes, manifestations and treatment. Br J Hosp Med (Lond) 2006;67:654-657
85. Bernstein JA, Levy R, Wasserman RL, Bewtra A, Hurewitz D, Obtulowicz K, Reshef A, Kiessling PC, Craig TJ. Treatment of acute abdominal and facial attacks of hereditary angioedema (HAE) with human C1-esterase inhibitor (C1-INH): results of a global, multicenter, randomized, placebo-controlled, phase II /III study (I.M.P.A.C.T. 1). Presented at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology, Philadelphia, March 14-18, 2008
86. Craig TJ, Wasserman RL, Levy R, Bewtra A, Hurewitz D, Peters C, Kiessling PC. C1-esterase inhibitor (C1-INH)-standard of care for the treatment of acute attacks in hereditary angioedema (HAE): initial results of an ongoing, prospective, open-label study in North America (I.M.P.A.C.T. 2). Presented at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology, Philadelphia, March 14-18, 2008
87. van Doorn MB, Burggraaf J, van Dam T, Eerenberg A, Levi M, Hack CE, Schoemaker RC, Cohen AF, Nuijens J. A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema. J Allergy Clin Immunol 2005;116:876-883
88. Choi G, Soeters MR, Farkas H, Varga L, Obtulowicz K, Bilo B, Porebski G, Hack CE, Verdonk R, Nuijens J, Levi M. Recombinant human C1-inhibitor in the treatment of acute angioedema attacks. Transfusion 2007;47:1028-1032
89. European Medicines Agency. Questions and Answers on Recommendation for the Refusal of the Marketing Authorisation for Rhucin, 2008. http://www.ema.europa.eu/pdfs/ human/opinion/Q&A-Rhucin-14310508en.pdf
90. Liu D, Cramer CC, Scafidi J, Davis AE III. N-linked glycosylation at Asn3 and the positively charged residues within the amino-terminal domain of the c1 inhibitor are required for interaction of the C1 inhibitor with Salmonella enterica serovar typhimurium lipopolysaccharide and lipid A. Infect Immun 2005;73:4478-4487
91. Liu D, Lu F, Qin G, Fernandes SM, Li J, Davis AE III. C1 inhibitor-mediated protection from sepsis. J Immunol 2007;179:3966-3972
92. Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J Allergy Clin Immunol 2007;119:1497-1503
93. Bernstein JA. Hereditary angioedema: a current state-of-theart review, VIII: current status of emerging therapies. Ann Allergy Asthma Immunol 2008;100:S41-46
94. Levy JH, O'Donnell PS. The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema. Expert Opin Investig Drugs 2006;15:1077-1090
95. Caballero T, Lopez-Serrano C. Anaphylactic reaction and antibodies to DX-88 (kallikrein inhibitor) in a patient with hereditary angioedema. J Allergy Clin Immunol 2006;117:476-7; discussion 477
96. Schneider L, Lumry W, Vegh A, Williams AH, Schmalbach T. Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor. J Allergy Clin Immunol 2007;120:416-422
97. Cicardi M, Frangi D, Bergamaschini L, Gardinali M, Sacchi G, Agostoni A. Acquired C1 inhibitor deficiency with angioedema symptoms in a patient infected with Echinococcus granulosus. Complement 1985;2:133-139
98. Farkas H, Gyeney L, Majthenyi P, Fust G, Varga L. Angioedema due to acquired C1-esterase inhibitor deficiency in a patient with Helicobacter pylori infection. Z Gastroenterol 1999;37:513-518
99. Nielsen EW, Gran JT, Straume B, Mellbye OJ, Johansen HT, Mollnes TE. Hereditary angio-oedema: new clinical observations and autoimmune screening, complement and kallikreinkinin analyses. J Intern Med 1996;239:119-130
100. Rais M, Unzeitig J, Grant JA. Refractory exacerbations of hereditary angioedema with associated Helicobacter pylori infection. J Allergy Clin Immunol 1999;103:713-714
101. Varvarovska J, Sykora J, Stozicky F, Chytra I. Acquired angioedema and Helicobacter pylori infection in a child. Eur J Pediatr 2003;162:707-709
102. Watson RD, Gershwin ME. Acquired angioedema associated with sinusitis. J Investig Allergol Clin Immunol 2000;10:129-134
103. Weidenbach H, Beckh KH, Lerch MM, Adler G. Precipitation of hereditary angioedema by infectious mononucleosis. Lancet 1993;342:934
104. Bork K, Fischer B, Dewald G. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med 2003;114:294-298
105. Borradori L, Marie O, Rybojad M, Vexiau P, Morel P, Spath P. Hereditary angioedema and oral contraception. Dermatologica 1990;181:78-79
106. Bouillet L, Ponard D, Drouet C, Jullien D, Massot C. Angioedema and oral contraception. Dermatology 2003;206:106-109
107. Yip J, Cunliffe WJ. Hormonally exacerbated hereditary angioedema. Australas J Dermatol 1992;33:35-38
108. Kunschak M, Engl W, Maritsch F, Rosen FS, Eder G, Zerlauth G, Schwarz HP. A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema. Transfusion 1998;38:540-549
109. Fay A, Abinun M. Current management of hereditary angiooedema (C'1 esterase inhibitor deficiency). J Clin Pathol 2002;55:266-270
110. Postnikoff IM, Pritzker KP. Hereditary angioneurotic edema: an unusual case of maternal mortality. J Forensic Sci 1979;24:473-478
111. Stiller RJ, Kaplan BM, Andreoli JW Jr. Hereditary angioedema and pregnancy. Obstet Gynecol 1984;64:133-135
112. Jensen NF, Weiler JM. C1 esterase inhibitor deficiency, airway compromise, and anesthesia. Anesth Analg 1998;87:480-488
113. Bork K, Barnstedt SE. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch Intern Med 2001;161:714-718
114. Duvvur S, Khan F, Powell K. Hereditary angioedema and pregnancy. J Matern Fetal Neonatal Med 2007;20:563-565
115. Hermans C. Successful management with C1-inhibitor concentrate of hereditary angioedema attacks during two successive pregnancies: a case report. Arch Gynecol Obstet 2007;276:271-276
116. Levi M, Choi G, Picavet C, Hack CE. Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. J Allergy Clin Immunol 2006;117:904-908
117. Longhurst HJ, Carr S, Khair K. C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option. Clin Exp Immunol 2007;147:11-17
118. Jaffe CJ, Atkinson JP, Gelfand JA, Frank MM. Hereditary angioedema: the use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery. J Allergy Clin Immunol 1975;55:386-393
119. Wall RT, Frank M, Hahn M. A review of 25 patients with hereditary angioedema requiring surgery. Anesthesiology 1989;71:309-311
120. Degroote DF, Smith GL, Huttula GS. Acute airway obstruction following tooth extraction in hereditary angioedema. J Oral Maxillofac Surg 1985;43:52-54
121. Bonser RS, Dave J, Morgan J, Morgan C, Davies E, Taylor P, Gaya H, John L, Paneth M, Vergani D. Complement activation during bypass in acquired C1 esterase inhibitor deficiency. Ann Thorac Surg 1991;52:541-543
122. Haering JM, Comunale ME. Cardiopulmonary bypass in hereditary angioedema. Anesthesiology 1993;79:1429-1433
123. Spath PJ, Wuthrich B, Butler R. Quantification of C1-inhibitor functional activities by immunodiffusion assay in plasma of patients with hereditary angioedema-evidence of a functionally critical level of C1-inhibitor concentration. Complement 1984;1:147-159
124. Leimgruber A, Jaques WA, Spaeth PJ. Hereditary angioedema: uncomplicated maxillofacial surgery using short-term C1 inhibitor replacement therapy. Int Arch Allergy Immunol 1993;101:107-112
125. Witschi A, Krahenbuhl L, Frei E, Saltzman J, Spath PJ, Muller UR. Colorectal intussusception: an unusual gastrointestinal complication of hereditary angioedema. Int Arch Allergy Immunol 1996;111:96-98
126. Lehmann A, Lang J, Boldt J, Saggau W. Successful off-pump coronary artery bypass graft surgery in a patient with hereditary angioedema. J Cardiothorac Vasc Anesth 2002;16:473-476